Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Operating Expenses: 2009-2021

Historic Operating Expenses for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to $85.5 million.

  • Avadel Pharmaceuticals' Operating Expenses rose 62.24% to $23.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $85.5 million, marking a year-over-year increase of 417.86%. This contributed to the annual value of $85.5 million for FY2021, which is 417.86% up from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Operating Expenses stood at $85.5 million for FY2021, which was up 417.86% from $16.5 million recorded in FY2020.
  • In the past 5 years, Avadel Pharmaceuticals' Operating Expenses ranged from a high of $208.2 million in FY2018 and a low of $16.5 million during FY2020.
  • For the 3-year period, Avadel Pharmaceuticals' Operating Expenses averaged around $61.8 million, with its median value being $83.3 million (2019).
  • As far as peak fluctuations go, Avadel Pharmaceuticals' Operating Expenses tumbled by 80.18% in 2020, and later skyrocketed by 417.86% in 2021.
  • Yearly analysis of 5 years shows Avadel Pharmaceuticals' Operating Expenses stood at $83.7 million in 2017, then spiked by 148.62% to $208.2 million in 2018, then plummeted by 59.98% to $83.3 million in 2019, then plummeted by 80.18% to $16.5 million in 2020, then surged by 417.86% to $85.5 million in 2021.